SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response: 0.5

1. Name and Address of Reporting Person* LOVE TED W (Last) (First) (Middle) C/O KALOBIOS PHARMACEUTICALS, INC. 260 EAST GRAND AVENUE (Street) SOUTH SAN FRANCISCO CA 94080 (City) (State) (Zip)	2. Date of Event Requiring Statement (Month/Day/Year) 08/11/2012	3. Issuer Name and Ticker or Trading Symbol KALOBIOS PHARMACEUTICALS INC [ KBIO ]
		4. Relationship of Reporting Person(s) to Issuer (Check all applicable) X Director 10% Owner Officer (give title below) Other (specify below)	5. If Amendment, Date of Original Filed (Month/Day/Year) 08/10/2012
			6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	(1)	04/01/2019	Common Stock	50,000	$0.34	D
Stock Option (right to buy)	(2)	02/24/2020	Common Stock	25,000	$0.41	D
Stock Option (right to buy)	(3)	01/26/2021	Common Stock	25,000	$0.41	D
Stock Option (right to buy)	(4)	03/12/2022	Common Stock	12,500	$0.61	D

Explanation of Responses:

1. This option, representing a right to purchase a total of 50,000 shares of Common Stock, is immediately exercisable and vests over 4 years of service from March 1, 2009, with 25% vesting upon completion of one year of service and 75% vesting in 36 equal monthly installments thereafter.

2. This option, representing a right to purchase a total of 25,000 shares of Common Stock, is immediately exercisable and vests ratably over 48 months of service from January 1, 2010.

3. This option, representing a right to purchase a total of 25,000 shares of Common Stock, is immediately exercisable and vests ratably over 48 months of service from January 1, 2011.

4. This option, representing a right to purchase a total of 12,500 shares of Common Stock, is immediately exercisable and vests ratably over 48 months of service from January 1, 2012.

Remarks:

This amendment is being filed only to (i) add and attach the power of attorney in Exhibit 24.1 and (ii) correct the Date of Event Requiring Statement. This Form 3/A does not reflect the 1-for-3.56147 reverse stock split which became effective on January 15, 2013.

	/s/ Bhavit Sheth, attorney-in-fact	05/02/2013
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.